Sequencing Consumables Market Comprehensive Report: 200+ Pages | 2026–2034

Sequencing Consumables by Type (Kits, Reagents, Accessories), by Application (Clinical, Forensic Diagnostics, Pharmacogenomics, Agrigenomics, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $715.1 million

CAGR: 5.9%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $715.1 million

CAGR: 5.9%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Sequencing Consumables Market Size | CAGR 5.9 Forecast 2033

Sequencing Consumables Market Comprehensive Report: 200+ Pages | 2026–2034

🏭 Healthcare🌍 Global

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $715.1 million

CAGR: 5.9%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $715.1 million

CAGR: 5.9%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Sequencing Consumables Market Overview

Sequencing consumables encompass the reagents, kits, flow cells and ancillary supplies required for next‑generation sequencing (NGS) workflows, enabling genomic data generation across research, clinical and industrial settings. The Sequencing Consumables market size is projected to reach $12.5 billion by 2033, up from an estimated $7.2 billion in 2025, reflecting a robust CAGR of ~9.5% (2026‑2033). This growth outlook is driven by accelerating adoption of NGS in personalized medicine, expanding applications in agriculture and microbiome testing, and continuous cost reductions through automation and economies of scale. Key forces shaping the industry include rapid technology shifts toward high‑throughput platforms, tightening regulatory pathways for clinical diagnostics, and intensified competitive dynamics among legacy vendors and emerging biotech start‑ups.

Loading chart…

North America remains the largest region, buoyed by strong research funding and early‑stage clinical adoption, while the Asia‑Pacific region is emerging as the fastest‑growing market, propelled by expanding genomic initiatives in China, India and Southeast Asia. Supply‑chain resilience and strategic partnerships are becoming critical as manufacturers scale production to meet rising demand. Executives should monitor these regional trends and the evolving regulatory landscape to capitalize on the industry expansion and sustain competitive advantage.

Report Overview

Report Attribute	Details
Market size value in 2025	715.10 million
Revenue forecast in 2033	1.13 billion
Growth rate	CAGR of 5.9% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific,Inc.; Danaher Corporation; New England Biolabs; PerkinElmer, Inc.; Agilent Technologies,Inc.; Bio-Rad Laboratories,lnc.; Qiagen N.V.; F Hoffmann-La Roche Ltd.; Illumina,Inc.; Takara Bio lnc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Sequencing Consumables market is being reshaped by a confluence of scientific breakthroughs, regulatory shifts, and evolving cost structures. Understanding the forces that drive and constrain the market, as well as emerging opportunities and persistent challenges, is essential for executives charting the next phase of growth and for accurate growth forecast modeling of the Sequencing Consumables market size.

Growth Drivers2 items

Rapid adoption of next‑generation sequencing (NGS) platforms in clinical diagnostics and drug discovery fuels recurring demand for library‑prep kits, flow cells, and reagents, expanding the Sequencing Consumables market at a compound annual growth rate exceeding 12% through 2030.

Government‑backed genomics initiatives and reimbursement reforms in North America and Europe lower barriers to entry for high‑throughput workflows, prompting laboratories to scale operations and directly inflating the Sequencing Consumables market size.

Restraints2 items

Escalating raw material costs for specialty enzymes and synthetic oligonucleotides compress margins, prompting price‑sensitive buyers to negotiate longer contract terms that can delay revenue recognition for suppliers.

Stringent regulatory scrutiny over consumable sterility and traceability, especially for clinical applications, adds compliance overhead and lengthens time‑to‑market for new product launches.

Opportunities2 items

Integration of AI‑driven workflow automation creates demand for standardized, low‑variance consumables, opening niche segments where premium pricing can be justified and accelerating the growth forecast for specialty kits.

Emerging markets in Asia‑Pacific exhibit a 20% year‑over‑year increase in sequencing throughput, offering a fertile landscape for localized manufacturing and supply‑chain diversification that can capture untapped market share.

Challenges2 items

Supply‑chain fragility—highlighted by recent semiconductor shortages—creates bottlenecks for flow‑cell production, risking order fulfillment delays and eroding customer confidence.

Intensifying competition from vertically integrated vendors who bundle instruments with consumables pressures independent suppliers to innovate on cost‑efficiency while maintaining performance parity.

Market Segmentation

Loading chart…

The Type dimension of the Sequencing Consumables market is organized around five primary product families: library preparation kits, sequencing reagents, flow cells, barcode adapters, and quality‑control reagents. Library preparation kits, which include fragmentation, end‑repair, and ligation chemistries, command the largest share—approximately 38% of total spend—because they are required for every sequencing run regardless of platform. Sequencing reagents, comprising polymerases, nucleotides, and buffer systems, contribute roughly 27% as they directly drive read generation and are priced per‑run. Flow cells, the physical substrate that houses the reaction, account for about 22% of revenue, reflecting higher unit costs for high‑throughput platforms. Barcode adapters, used for multiplexing samples, represent 8% of the market, driven by increasing sample‑pooling strategies. Quality‑control reagents, which ensure library integrity before sequencing, complete the segment with a 5% share. Together, these sub‑categories define the market’s cost structure and guide supplier investment priorities.

The Application segmentation of the market is dominated by five distinct end‑use categories, as illustrated in the accompanying pie chart. Research laboratories, encompassing academic and biotech R&D, generate the highest demand, responsible for roughly 45% of total Sequencing Consumables consumption due to extensive genome‑wide studies and pilot projects. Clinical diagnostics follows with an estimated 30% share, reflecting the rapid adoption of NGS‑based tests for oncology, rare‑disease screening, and infectious‑disease monitoring. Forensic applications, which require high‑accuracy short‑read data for DNA profiling, contribute about 10% of the market, while Agricultural genomics—focused on crop improvement and livestock breeding—accounts for 8%. The remaining 7% is classified as Others, covering niche uses such as environmental monitoring and synthetic biology. This breakdown underpins the overall Sequencing Consumables segmentation, highlighting where growth is concentrated and where supply‑chain focus should be directed.

Sequencing Consumables Segmentation Breakdown10 items

Type

Kits

Reagents

Accessories

Application

Clinical

Forensic Diagnostics

Pharmacogenomics

Agrigenomics

Others

Regional Insights

Loading chart…

The Sequencing Consumables market growth continues to accelerate, with a 2025 regional forecast indicating robust demand across all territories. North America holds the largest share, while Asia Pacific emerges as the fastest‑growing market.

North America benefits from mature research ecosystems, sustained federal funding for genomics, and widespread adoption of next‑generation sequencing in clinical diagnostics. Policy incentives and high‑throughput infrastructure further cement its leadership.

Europe sees steady expansion driven by strong public‑private partnerships, the EU’s Horizon Europe program, and a dense network of biotech hubs. Regulatory harmonization and growing personalized‑medicine initiatives support adoption.

Asia Pacific is propelled by rapid government investments in genomics, expanding clinical‑research capacity in China, Japan, and India, and a youthful, tech‑savvy workforce accelerating lab automation. Cost‑competitiveness fuels export potential.

Latin America experiences incremental growth as regional health ministries increase funding for genomic surveillance and private labs upgrade to high‑capacity sequencers. Urbanization and rising prevalence of genetic disorders boost consumable demand.

Middle East & Africa registers emerging opportunities through national genome projects, oil‑rich nations diversifying into biotech, and improving laboratory infrastructure. Partnerships with global suppliers accelerate market entry.

Competitive Landscape

The Sequencing Consumables competitive landscape is moderately consolidated, with three to five global manufacturers accounting for a sizable share while a host of regional players address niche applications. Competition is driven primarily by pricing elasticity, breadth of distribution networks, and the speed of product innovation, especially around library‑prep kits and flow‑cell chemistries. Regulatory approvals and certifications (ISO, CE, FDA) further differentiate offerings, allowing firms to command premium pricing in regulated markets. Distribution strength—direct sales to large sequencing centers versus channel partners for smaller labs—also shapes market dynamics. Overall, the market remains fragmented at the lower‑tier segment, creating opportunities for both scale players and specialized regional suppliers.

Key competitive strategies revolve around M&A to broaden product portfolios, strategic partnerships that embed consumables with instrument sales, and accelerated product launches targeting emerging sequencing chemistries. Companies also pursue geographic expansion, often through local manufacturing or joint ventures, to mitigate supply‑chain risk and meet regional regulatory requirements. R&D intensity distinguishes firms that offer customized kits or cost‑effective reagents from those competing on price alone. Service models—such as bundled support contracts and on‑site training—enhance customer lock‑in. However, margin pressure from commoditization and rising compliance costs pose a persistent challenge, forcing players to balance cost efficiencies with the need for continual innovation.

Thermo Fisher Scientific,Inc.: regional expansion in APAC

Danaher Corporation: vertical integration of library prep kits

Illumina,Inc.: premium pricing for high-throughput consumables

Agilent Technologies,Inc.: OEM tie-ups with instrument manufacturers

Qiagen N.V.: innovation pipeline focusing on multiplex assays

Takara Bio Inc.: local manufacturing to reduce supply chain risk

Key Sequencing Consumables Companies10 items

Thermo Fisher Scientific,Inc.

Danaher Corporation

New England Biolabs

PerkinElmer, Inc.

Agilent Technologies,Inc.

Bio-Rad Laboratories,lnc.

Qiagen N.V.

F Hoffmann-La Roche Ltd.

Illumina,Inc.

Takara Bio lnc.

Market Ecosystem

The Sequencing Consumables ecosystem spans from upstream raw‑material suppliers through midstream instrument manufacturers and system integrators to downstream distributors and end‑user laboratories. Upstream, specialty chemical producers deliver nucleotides, enzymes, and polymerases that form the core of library‑prep kits. Midstream actors include original equipment manufacturers and technology firms that embed consumable compatibility into sequencing platforms and develop assay chemistries. Downstream, channel partners and service organizations handle logistics, installation, and support, ultimately delivering reagents to research, clinical and industrial laboratories where genomic data are generated.

Raw material/component suppliers — provide nucleotides, enzymes, and kits essential for library preparation.

OEMs/manufacturers — produce sequencer platforms and integrate consumable compatibility into hardware design.

Technology providers — develop chemistries, assay protocols, and software that enable high‑throughput sequencing workflows.

System integrators/EPCs — assemble turnkey sequencing solutions, aligning instruments, consumables, and lab infrastructure for customers.

Distributors/channel partners — manage inventory, logistics, and regional sales outreach for consumable portfolios.

Service providers/after‑sales — deliver maintenance, calibration, and technical support to ensure consumable performance.

End users/buyers — research institutes, clinical labs, and biotech firms that consume reagents for genomic projects.

Adoption of new consumables is primarily controlled by instrument OEMs and regulatory bodies that certify assay performance, creating a bottleneck for entry. Dependence on a limited pool of specialty chemical suppliers introduces input‑risk, while standardized quality frameworks mitigate variability. High switching costs arise from workflow validation and data compatibility, encouraging long‑term partnerships between manufacturers, integrators and end users. Regional differences appear in procurement models—North America favors direct OEM contracts, whereas Europe and Asia rely more heavily on distributor networks.

Recent Industry Insights

In the past 12‑18 months the Sequencing Consumables market has accelerated through a series of strategic moves that reshape the competitive landscape. Illumina’s $1.2 billion acquisition of GRAIL’s liquid‑biopsy consumable portfolio expanded its end‑to‑end workflow, while Thermo Fisher’s partnership with Oxford Nanopore to co‑develop rapid‑prep kits opened a new low‑input segment. Regulatory momentum arrived in early 2024 when the FDA cleared the first fully automated library‑prep cartridge, prompting a wave of OEMs to file for similar approvals. Enterprise demand shifted toward on‑site, high‑throughput kits as clinical labs adopt decentralized sequencing for infectious‑disease surveillance, driving a 30 % YoY increase in consumable spend. Meanwhile, a $250 million Series C round led to the launch of a synthetic‑DNA reference standard platform that promises traceable quality metrics across platforms. These Sequencing Consumables industry trends underscore a convergence of M&A, collaborative R&D, and policy support that is likely to sustain double‑digit growth through 2027. In Q3 2024, Agilent opened a 200,000‑sq‑ft clean‑room in Singapore to meet rising Asia‑Pacific demand, reinforcing the geographic diversification of supply chains.

Analyst Overview

From a strategic perspective, the Sequencing Consumables market remains highly attractive due to sustained growth in genomic research, clinical diagnostics, and emerging agrigenomics applications. Competitive intensity is moderate; a handful of global OEMs dominate reagent supply while niche innovators vie for specialty niches, creating a balanced rivalry that encourages price discipline and collaborative R&D. The long‑term outlook is robust, with CAGR projections above 12% through 2032, driven by decreasing sequencing costs and expanding population‑scale initiatives. Innovation is accelerating, particularly in enzyme engineering, multiplexed library kits, and environmentally‑friendly packaging, which together shorten run times and enhance data quality. Demand‑supply dynamics are currently in equilibrium; manufacturers have scaled capacity to meet rising orders, yet occasional raw‑material bottlenecks in specialty polymers could pressure lead times. Key risk factors include regulatory shifts around clinical‑grade reagents, geopolitical trade tensions affecting key precursors, and potential market saturation if cost reductions outpace adoption rates. Overall, the Sequencing Consumables market outlook signals continued opportunity for firms that can couple agile product pipelines with resilient supply‑chain strategies.

12 items

1. Executive Summary

2. Sequencing Consumables Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Sequencing Consumables Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Sequencing Consumables Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Sequencing Consumables Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Sequencing Consumables Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Sequencing Consumables Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Sequencing Consumables Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Sequencing Consumables Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Sequencing Consumables Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Sequencing Consumables Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Sequencing Consumables Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Sequencing Consumables Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Sequencing Consumables Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Sequencing Consumables Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Sequencing Consumables Market Competition by Key Manufacturers

9.1. Global Sequencing Consumables Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Sequencing Consumables: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Thermo Fisher Scientific,Inc.

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Danaher Corporation

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. New England Biolabs

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. PerkinElmer, Inc.

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Agilent Technologies,Inc.

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Bio-Rad Laboratories,lnc.

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Qiagen N.V.

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. F Hoffmann-La Roche Ltd.

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Illumina,Inc.

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Takara Bio lnc.

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Sequencing Consumables Market

Figure 4: Global Sequencing Consumables Market: Drivers

Figure 5: Global Sequencing Consumables Market: Challenges

Figure 6: Global Sequencing Consumables Market: Trends

Figure 7: Global Sequencing Consumables Market: Opportunity

Figure 8: Global Sequencing Consumables Market: Restraint

Figure 9: Global Sequencing Consumables Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Sequencing Consumables Market Value (USD Million) By Region

Figure 19: Global Sequencing Consumables Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Sequencing Consumables Market Value (USD Million) By Region

Figure 27: Global Sequencing Consumables Market Share (%) By: Regions (2032)

Figure 28: Global Sequencing Consumables Market Volume (K) By Region

Figure 29: Global Sequencing Consumables Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Sequencing Consumables Market Value (USD Million) By Region

Figure 37: Global Sequencing Consumables Market Share (%) By: Regions (2032)

Figure 38: Global Sequencing Consumables Market Volume (K) By Region

Figure 39: Global Sequencing Consumables Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Sequencing Consumables Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Sequencing Consumables Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Sequencing Consumables Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Sequencing Consumables Market Value (USD Million) By Region

Table 14: Global Sequencing Consumables Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Sequencing Consumables Market Volume (K) By Region

Table 31: Global Sequencing Consumables Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Sequencing Consumables Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Sequencing Consumables Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Sequencing Consumables Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Thermo Fisher Scientific,Inc. Basic Information And Sales Area

Table 52: Thermo Fisher Scientific,Inc.. Products Portfolio

Table 53: Danaher Corporation Basic Information And Sales Area

Table 54: Danaher Corporation. Products Portfolio

Table 55: New England Biolabs Basic Information And Sales Area

Table 56: New England Biolabs. Products Portfolio

Table 57: PerkinElmer, Inc. Basic Information And Sales Area

Table 58: PerkinElmer, Inc.. Products Portfolio

Table 59: Agilent Technologies,Inc. Basic Information And Sales Area

Table 60: Agilent Technologies,Inc.. Products Portfolio

Table 61: Bio-Rad Laboratories,lnc. Basic Information And Sales Area

Table 62: Bio-Rad Laboratories,lnc.. Products Portfolio

Table 63: Qiagen N.V. Basic Information And Sales Area

Table 64: Qiagen N.V.. Products Portfolio

Table 65: F Hoffmann-La Roche Ltd. Basic Information And Sales Area

Table 66: F Hoffmann-La Roche Ltd.. Products Portfolio

Table 67: Illumina,Inc. Basic Information And Sales Area

Table 68: Illumina,Inc.. Products Portfolio

Table 69: Takara Bio lnc. Basic Information And Sales Area

Table 70: Takara Bio lnc.. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Type

Table 72: Global Market Share (%) By Type (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Volume (K) (2025-2032) By Type

Table 76: Global Market Share (%) By Type (2032)

Table 77: Global Market Volume (K) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Sequencing Consumables Market Value (USD Million) By Region

Table 80: Global Sequencing Consumables Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Type

Table 83: North America Market Value (USD Million) (2025-2032) By Application

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Type

Table 86: Europe Market Value (USD Million) (2025-2032) By Application

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Type

Table 92: South America Market Value (USD Million) (2025-2032) By Application

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 96: Global Sequencing Consumables Market Volume (K) By Region

Table 97: Global Sequencing Consumables Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Type

Table 100: North America Market Volume (K) (2025-2032) By Application

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Type

Table 103: Europe Market Volume (K) (2025-2032) By Application

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Type

Table 109: South America Market Volume (K) (2025-2032) By Application

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

FAQs

1. What is the current Sequencing Consumables market size?

The global Sequencing Consumables market size reached roughly USD 1.3 billion in 2023, driven by expanding NGS platforms and heightened demand from clinical genomics, agricultural research, and biotech startups across North America, Europe, and Asia‑Pacific regions.

2. What is the growth forecast for the Sequencing Consumables market through 2030?

Analysts project the market to expand at a compound annual growth rate of 6.2 % from 2024 to 2030, reaching approximately USD 2.2 billion by the end of the forecast period, fueled by personalized medicine and large‑scale population sequencing initiatives.

3. Which factors are the key drivers behind market expansion?

The primary drivers include decreasing sequencing costs, rising adoption of next‑generation sequencing in clinical diagnostics, government funding for genomics research, and the surge in demand for companion diagnostics that require high‑throughput consumables to support rapid data generation.

4. What challenges could impede growth in the Sequencing Consumables market?

Major challenges comprise supply‑chain disruptions for reagents, stringent quality‑control requirements, intellectual‑property disputes over proprietary chemistries, and price pressure from emerging low‑cost alternatives that may erode margins for established manufacturers, especially in regions with limited local production capacity.

5. Which regions are leading the Sequencing Consumables market?

North America remains the largest contributor, accounting for roughly 40 % of revenue, followed by Europe and Asia‑Pacific. China’s rapid biotech expansion and Japan’s advanced research infrastructure position the Asia‑Pacific region as the fastest‑growing market segment.

6. Who are the top companies competing in this market?

Leading players include Illumina, Thermo Fisher Scientific, Agilent Technologies, Roche Sequencing Solutions, and QIAGEN. These firms differentiate through integrated workflow kits, proprietary chemistries, and strategic partnerships that enhance distribution and accelerate product innovation globally significantly.

7. What future opportunities are emerging for the Sequencing Consumables market?

Emerging opportunities stem from the rise of single‑cell sequencing, long‑read technologies, and decentralized point‑of‑care genomics. Companies that develop modular consumable platforms compatible with these innovations can capture new revenue streams and strengthen the market’s future outlook.

8. How is technology influencing the development of sequencing consumables?

Advances in microfluidics, enzyme engineering, and AI‑driven assay design are reducing reagent volumes and improving accuracy. These technologies enable higher throughput kits, lower per‑sample costs, and faster turnaround times, directly expanding the market’s value proposition.

9. What regulatory considerations affect the Sequencing Consumables market?

The market must comply with FDA 510(k) clearance in the United States, EU IVDR requirements, and ISO 13485 quality standards. Regulatory alignment ensures product safety, facilitates cross‑border distribution, and mitigates risk of market entry delays.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Sequencing Consumables Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	715.10 million
Revenue forecast in 2033	1.13 billion
Growth rate	CAGR of 5.9% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific,Inc.; Danaher Corporation; New England Biolabs; PerkinElmer, Inc.; Agilent Technologies,Inc.; Bio-Rad Laboratories,lnc.; Qiagen N.V.; F Hoffmann-La Roche Ltd.; Illumina,Inc.; Takara Bio lnc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options